The Netherlands Organisation for Scientific Research (NWO) has awarded a so-called centre subsidy to two research centres which are currently being established. Each centre will receive a total of 1.35 million euros. These funds must be used by the centres over the next five years to carry out multidisciplinary research towards the prevention, management or treatment of infectious diseases in the Netherlands or in developing countries. The focus is on flu, AIDS, malaria and tuberculosis.

Flu vaccine
Under the leadership of Prof. J.C. (]an) Wilschut, Departments of Medical Microbiology and Molecular Virology, University of Groningen In this centre, named NIVAREC (Netherlands Influenza Vaccine Research Centre), researchers from the University of Groningen and the Erasmus MC Rotterdam will work together with researchers from Solvay Pharmaceuticals in Weesp. The centre wants to develop and produce new flu vaccines to ensure that the Netherlands is optimally prepared for a flu pandemic.

AIDS, malaria and tuberculosis
Under the leadership of Prof. J.W.M. (Jos) van der Meer, Department of General Internal Medicine, Nijmegen University Medical Centre This centre, named PRIOR (Poverty Relationship Infection Oriented Research), forms a unique cooperation for the control of poverty-related infectious diseases in the third world. Researchers from Nijmegen University Medical Centre, Leiden University Medical Center, Universiteit Maastricht, Wageningen University and Research Centre and the National Institute of Public Health and the Environment (RIVM) will work together with colleagues in Tanzania and Indonesia. The aim is to develop a knowledge infrastructure in third world countries for poverty-related infectious diseases.

The subsidy for research centres is one of the initiatives from ZonMw (Netherlands Organisation for Health Research and Development) and NWO to stimulate research into infectious diseases. In 2002 TOPIZ,
'"/>

Contact: Sonja Jacobs
news@nwo.nl
Netherlands Organization for Scientific Research
5-Feb-2004

Page: 1 2
Related medicine news :

1. New Canadian study demonstrates clear survival benefit of treatment in trials and at large centres
2. Medically supervised injecting centres should be piloted in the UK
3. Walk-in centres perform well compared with general practice
4. High brain centres teach lower brain to adapt to injury
5. Physicians call for increased funding for federal infectious disease programs
6. Mailman School of Public Health researchers develop infectious disease diagnostic tool
7. Childrens Hospital Oakland opens new $5.6 million infectious disease lab
8. NIAID launches program to improve medical tools against emerging infectious diseases
9. Study suggests better use of web could improve infectious disease reporting
10. International public health expert Jeffrey Koplan addresses emerging infectious diseases conference
11. The lancet infectious diseases (TLID) October press release